![Richard Limehouse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Limehouse
Directeur/Membre du Conseil chez GeneVentiv Therapeutics, Inc.
Provenance du réseau au premier degré de Richard Limehouse
Entité | Type d'entité | Industrie | |
---|---|---|---|
GeneVentiv Therapeutics, Inc.
![]() GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race.
2
| Holding Company | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Richard Limehouse via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Nabgen, Inc. | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 2 |
Sectorielle
Opérationnelle
Director/Board Member | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
President | 1 |
Relations les plus connectées
Insiders | |
---|---|
Chengwen Li | 2 |
Damon R Race | 1 |
- Bourse
- Insiders
- Richard Limehouse
- Connexions Sociétés